title: Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
authors.affiliation: Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands.
authors.forename: R
authors.initials: R
authors.lastname: Willemze
authors.forename: E
authors.initials: E
authors.lastname: Hodak
authors.forename: P L
authors.initials: PL
authors.lastname: Zinzani
authors.forename: L
authors.initials: L
authors.lastname: Specht
authors.forename: M
authors.initials: M
authors.lastname: Ladetto
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D005060:Europe / Q000453:epidemiology; D006801:Humans; D017730:Ki-1 Antigen / Q000378:metabolism; D008198:Lymph Nodes / Q000473:pathology; D054391:Lymphoma, Extranodal NK-T-Cell / Q000175:diagnosis / Q000188:drug therapy / Q000532:radiotherapy; D054446:Lymphoma, Primary Cutaneous Anaplastic Large Cell / Q000175:diagnosis / Q000628:therapy; D016399:Lymphoma, T-Cell / Q000188:drug therapy / Q000401:mortality; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D009182:Mycosis Fungoides / Q000175:diagnosis / Q000188:drug therapy / Q000532:radiotherapy; D009367:Neoplasm Staging; D015434:Panniculitis / Q000188:drug therapy / Q000401:mortality; D049268:Positron-Emission Tomography; D012751:Sezary Syndrome / Q000188:drug therapy / Q000532:radiotherapy; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D017730:Ki-1 Antigen